Title |
Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder
|
---|---|
Published in |
Psychopharmacology, April 2004
|
DOI | 10.1007/s00213-004-1874-y |
Pubmed ID | |
Authors |
Alexandra S. Potter, Paul A. Newhouse |
Abstract |
Adolescents with attention-deficit/hyperactivity disorder (ADHD) become cigarette smokers at twice the rate of non-ADHD adolescents, and this finding continues into adulthood. Abnormal cognitive/behavioral inhibition is one core cognitive symptom of ADHD, leading to impulsive behavior in people with this disorder. Nicotine, contained in tobacco smoke, is known to improve attention, vigilance, and short-term memory. However, little is known about how nicotine might effect cognitive/behavioral inhibition. |
X Demographics
The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 8 | 31% |
Canada | 5 | 19% |
Finland | 1 | 4% |
Comoros | 1 | 4% |
Australia | 1 | 4% |
United Kingdom | 1 | 4% |
Germany | 1 | 4% |
Unknown | 8 | 31% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 23 | 88% |
Practitioners (doctors, other healthcare professionals) | 1 | 4% |
Science communicators (journalists, bloggers, editors) | 1 | 4% |
Unknown | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 156 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
United States | 1 | <1% |
Netherlands | 1 | <1% |
Unknown | 153 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 29 | 19% |
Student > Ph. D. Student | 27 | 17% |
Student > Master | 19 | 12% |
Researcher | 13 | 8% |
Student > Doctoral Student | 10 | 6% |
Other | 35 | 22% |
Unknown | 23 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 53 | 34% |
Medicine and Dentistry | 17 | 11% |
Neuroscience | 11 | 7% |
Agricultural and Biological Sciences | 11 | 7% |
Unspecified | 11 | 7% |
Other | 19 | 12% |
Unknown | 34 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2023.
All research outputs
#1,587,616
of 25,468,708 outputs
Outputs from Psychopharmacology
#375
of 5,331 outputs
Outputs of similar age
#1,980
of 62,665 outputs
Outputs of similar age from Psychopharmacology
#4
of 32 outputs
Altmetric has tracked 25,468,708 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,331 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 62,665 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.